Nucleic acid binding, RNA-binding
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HXC9
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003723 | RNA binding | 4 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 125 | 127 | PF00675 | 0.645 |
CLV_NRD_NRD_1 | 131 | 133 | PF00675 | 0.483 |
CLV_NRD_NRD_1 | 146 | 148 | PF00675 | 0.725 |
CLV_PCSK_FUR_1 | 92 | 96 | PF00082 | 0.662 |
CLV_PCSK_KEX2_1 | 131 | 133 | PF00082 | 0.611 |
CLV_PCSK_KEX2_1 | 146 | 148 | PF00082 | 0.586 |
CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.598 |
CLV_PCSK_KEX2_1 | 94 | 96 | PF00082 | 0.754 |
CLV_PCSK_PC1ET2_1 | 41 | 43 | PF00082 | 0.598 |
CLV_PCSK_PC1ET2_1 | 94 | 96 | PF00082 | 0.749 |
CLV_PCSK_SKI1_1 | 42 | 46 | PF00082 | 0.482 |
DEG_APCC_DBOX_1 | 243 | 251 | PF00400 | 0.513 |
DEG_APCC_DBOX_1 | 60 | 68 | PF00400 | 0.530 |
DEG_COP1_1 | 130 | 139 | PF00400 | 0.540 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.512 |
DOC_CYCLIN_yClb3_PxF_3 | 204 | 210 | PF00134 | 0.677 |
DOC_MAPK_gen_1 | 41 | 49 | PF00069 | 0.457 |
DOC_MAPK_MEF2A_6 | 244 | 253 | PF00069 | 0.534 |
DOC_MAPK_MEF2A_6 | 284 | 293 | PF00069 | 0.486 |
DOC_MAPK_MEF2A_6 | 42 | 51 | PF00069 | 0.442 |
DOC_PP2B_LxvP_1 | 180 | 183 | PF13499 | 0.574 |
DOC_PP2B_LxvP_1 | 197 | 200 | PF13499 | 0.612 |
DOC_PP4_FxxP_1 | 186 | 189 | PF00568 | 0.748 |
DOC_PP4_FxxP_1 | 253 | 256 | PF00568 | 0.562 |
DOC_USP7_MATH_1 | 165 | 169 | PF00917 | 0.571 |
DOC_USP7_MATH_1 | 30 | 34 | PF00917 | 0.484 |
DOC_USP7_UBL2_3 | 37 | 41 | PF12436 | 0.536 |
DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.745 |
LIG_14-3-3_CanoR_1 | 11 | 18 | PF00244 | 0.560 |
LIG_BIR_III_2 | 65 | 69 | PF00653 | 0.531 |
LIG_EVH1_2 | 182 | 186 | PF00568 | 0.577 |
LIG_FHA_1 | 280 | 286 | PF00498 | 0.486 |
LIG_FHA_1 | 44 | 50 | PF00498 | 0.471 |
LIG_FHA_2 | 138 | 144 | PF00498 | 0.551 |
LIG_FHA_2 | 19 | 25 | PF00498 | 0.526 |
LIG_FHA_2 | 48 | 54 | PF00498 | 0.548 |
LIG_LIR_Gen_1 | 113 | 120 | PF02991 | 0.665 |
LIG_LIR_Gen_1 | 12 | 22 | PF02991 | 0.460 |
LIG_LIR_Gen_1 | 231 | 240 | PF02991 | 0.546 |
LIG_LIR_Gen_1 | 45 | 56 | PF02991 | 0.429 |
LIG_LIR_Nem_3 | 113 | 117 | PF02991 | 0.653 |
LIG_LIR_Nem_3 | 12 | 18 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 231 | 236 | PF02991 | 0.472 |
LIG_LIR_Nem_3 | 24 | 28 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 45 | 51 | PF02991 | 0.413 |
LIG_MYND_1 | 205 | 209 | PF01753 | 0.640 |
LIG_PROFILIN_1 | 199 | 205 | PF00235 | 0.550 |
LIG_PTB_Apo_2 | 216 | 223 | PF02174 | 0.496 |
LIG_SH2_STAT3 | 120 | 123 | PF00017 | 0.680 |
LIG_SH2_STAT5 | 228 | 231 | PF00017 | 0.529 |
LIG_SH3_2 | 201 | 206 | PF14604 | 0.600 |
LIG_SH3_3 | 196 | 202 | PF00018 | 0.671 |
LIG_SH3_3 | 280 | 286 | PF00018 | 0.433 |
LIG_SH3_CIN85_PxpxPR_1 | 201 | 206 | PF14604 | 0.600 |
LIG_SUMO_SIM_anti_2 | 246 | 251 | PF11976 | 0.534 |
LIG_SUMO_SIM_par_1 | 273 | 280 | PF11976 | 0.561 |
LIG_TRAF2_1 | 81 | 84 | PF00917 | 0.747 |
LIG_WRC_WIRS_1 | 31 | 36 | PF05994 | 0.587 |
LIG_WRC_WIRS_1 | 48 | 53 | PF05994 | 0.543 |
LIG_WW_3 | 203 | 207 | PF00397 | 0.656 |
MOD_CK1_1 | 279 | 285 | PF00069 | 0.445 |
MOD_CK1_1 | 9 | 15 | PF00069 | 0.550 |
MOD_CK1_1 | 93 | 99 | PF00069 | 0.765 |
MOD_CK2_1 | 13 | 19 | PF00069 | 0.505 |
MOD_CK2_1 | 137 | 143 | PF00069 | 0.551 |
MOD_CK2_1 | 30 | 36 | PF00069 | 0.458 |
MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.556 |
MOD_GlcNHglycan | 233 | 236 | PF01048 | 0.358 |
MOD_GlcNHglycan | 279 | 282 | PF01048 | 0.429 |
MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.645 |
MOD_GlcNHglycan | 88 | 91 | PF01048 | 0.674 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.651 |
MOD_GSK3_1 | 137 | 144 | PF00069 | 0.734 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.532 |
MOD_GSK3_1 | 5 | 12 | PF00069 | 0.544 |
MOD_GSK3_1 | 84 | 91 | PF00069 | 0.711 |
MOD_N-GLC_1 | 159 | 164 | PF02516 | 0.722 |
MOD_N-GLC_1 | 266 | 271 | PF02516 | 0.383 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.562 |
MOD_NEK2_1 | 266 | 271 | PF00069 | 0.586 |
MOD_NEK2_1 | 5 | 10 | PF00069 | 0.538 |
MOD_NEK2_2 | 30 | 35 | PF00069 | 0.489 |
MOD_PIKK_1 | 93 | 99 | PF00454 | 0.581 |
MOD_PKA_2 | 10 | 16 | PF00069 | 0.592 |
MOD_PKA_2 | 130 | 136 | PF00069 | 0.706 |
MOD_Plk_1 | 18 | 24 | PF00069 | 0.511 |
MOD_Plk_1 | 42 | 48 | PF00069 | 0.488 |
MOD_Plk_4 | 43 | 49 | PF00069 | 0.472 |
MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.750 |
MOD_SUMO_rev_2 | 105 | 110 | PF00179 | 0.717 |
TRG_ER_diArg_1 | 146 | 149 | PF00400 | 0.737 |
TRG_ER_diArg_1 | 172 | 175 | PF00400 | 0.743 |
TRG_Pf-PMV_PEXEL_1 | 227 | 231 | PF00026 | 0.386 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZY5 | Leptomonas seymouri | 52% | 100% |
A0A1X0P0T6 | Trypanosomatidae | 36% | 100% |
A0A3Q8IAN2 | Leishmania donovani | 98% | 98% |
A0A3R7MFN4 | Trypanosoma rangeli | 36% | 100% |
A4H8Z8 | Leishmania braziliensis | 76% | 100% |
D0A4S0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
E9AR24 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
Q4QED9 | Leishmania major | 94% | 100% |
V5AZY6 | Trypanosoma cruzi | 37% | 100% |